IE00BYTRRB94
IE00BYTRRB94
State Street® SPDR® MSCI World Health Care UCITS ETF
Loading chart...
Analytics & Allocation
Detailed breakdown by growth drivers, valuation & quality, and asset allocation
Growth Drivers (Estimates)
Largest contributors to earnings and revenue growth
Sectors & Industries
Weight
Avg. Growth
Contribution
Balance Sheet & Financial Health
Aggregated leverage and valuation structure
Weighted P/E
27.82
Weighted Fwd P/E
17.93
Avg P/FCF
25.07
Avg FCF Yield
3.79%
Avg EV / EBITDA
17.25
Avg EV / Revenue
14.37
Avg Price-to-Book (P/B)
51.5
Avg Price-to-Sales (P/S)
15.54
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
-35.55%
Avg Debt-to-Equity (D/E)
164.81%
<50% (14.42%) 50-150% (54.79%) >150% (20.25%) Unreported (10.54%)
Profitability Analysis
111 Holdings CountProfitable 97.95%
Profitable 97.95%
106
Holdings Count (95.5%)
Unprofitable 2.05%
5
Holdings Count (4.5%)
ETF Concentration (Cumulative Weight)
Cumulative weight of positions (Lorenz curve)
Top 5
32.8%
Top 10
47.9%
Top 25
70.8%
50% Threshold
Top 11
The top 10 positions account for 47.9% of the portfolio. A healthy balance between a strong core and diversification. The steeper the curve initially rises, the more the largest positions dominate the fund volume.
Geographic Distribution
17 CountriesLoading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (17.9%+)
High (46.6%+)
Top (64.5%+)
Country Breakdown
Max: 71.67%71.67%
9.35%
5.08%
3.43%
2.05%
1.96%
1.52%
1.42%
1.09%
0.92%
0.55%
0.39%
0.18%
0.13%
0.12%
0.10%
0.06%
Sector Distribution
1 SectorHealthcare
100.00%
Industry Distribution
10 IndustriesDrug Manufacturers - General
53.37%
Diagnostics & Research
9.44%
Medical Devices
8.44%
Healthcare Plans
8.34%
Biotechnology
6.64%
Medical Instruments & Supplies
5.32%
Drug Manufacturers - Specialty & Generic
4.07%
Medical Distribution
2.66%
Other
1.72%
Market Cap Distribution
111 Holdings CountMega Cap (> 200B)
(11) 48.08%
Large Cap (10B - 200B)
(92) 51.31%
Mid Cap (2B - 10B)
(8) 0.61%